AdaptHealth vs Idexx Laboratories
Idexx Laboratories reported revenue of $4.3 billion in fiscal 2025, 1.3 times AdaptHealth's $3.2 billion in fiscal 2025. AdaptHealth's revenue fell 0.5% in its latest year, and Idexx Laboratories' grew 10.4%. AdaptHealth had an operating margin of 2.8%, against 31.6% at Idexx Laboratories. Free cash flow was $219 million at AdaptHealth and $1.1 billion at Idexx Laboratories.
Side by side
| AdaptHealth | Idexx Laboratories | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $3.2B | $4.3B |
| Revenue growth | −0.5% | 10.4% |
| Revenue growth a year, last 5 years | 25.2% | 9.7% |
| Gross margin | 18.8% | 61.8% |
| Operating margin | 2.8% | 31.6% |
| Net margin | −2.2% | 24.6% |
| Free cash flow | $219M | $1.1B |
| Free cash flow margin | 6.8% | 24.6% |
| Return on capital | 2.1% | 57.3% |
| Net debt to EBITDA | 3.5x | 0.2x |
| Dividends and buybacks | $0M | $1.2B |
| Change in diluted share count | −0.3% | −2.7% |
| Last close | $5.93 | $570.21 |
| P/E at the last close | — | 40.1× |
| Insider trades, last 12 months | bought $24.9 million, sold $278,287 | sold $37.7 million |
| Piotroski F-score | 4 of 9 | 8 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
AdaptHealthIdexx Laboratories
Operating margin
Percent of revenue
AdaptHealthIdexx Laboratories
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
AdaptHealthIdexx Laboratories
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the AdaptHealth and Idexx Laboratories pages.